These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33336061)

  • 1. A case of SLE with COVID-19 and multiple infections.
    Ning R; Meng S; Tang F; Yu C; Xu D; Luo X; Sun H
    Open Med (Wars); 2020; 15(1):1054-1060. PubMed ID: 33336061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on SLE.
    Zhao X; Wu H; Li S; Gao C; Wang J; Ge L; Song Z; Ni B; You Y
    Mod Rheumatol; 2024 Feb; 34(2):247-264. PubMed ID: 36961736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic.
    Sjöwall J; Azharuddin M; Frodlund M; Zhang Y; Sandner L; Dahle C; Hinkula J; Sjöwall C
    Front Immunol; 2021; 12():724047. PubMed ID: 34512651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
    Zurita MF; Iglesias Arreaga A; Luzuriaga Chavez AA; Zurita L
    Am J Case Rep; 2020 Sep; 21():e927304. PubMed ID: 32978364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus flare during SARS-CoV-2 infection: Report of 3 cases presented during the fourth wave of the pandemic in Colombia.
    Naranjo-Millán JA; Bedoya-Joaqui V; Cañas CA
    Int J Rheum Dis; 2023 Sep; 26(9):1807-1810. PubMed ID: 36880687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE).
    Anuforo A; Sandhu M; Yu J; Perl A
    Clin Immunol Commun; 2022 Dec; 2():54-56. PubMed ID: 38620676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study.
    Wu Y; Li Y; Wu T; Huang D; Wu J; Zhang W; Jiang X; Yao C; Liang X; Cheng L; Liao Z; Xu F; Tan C; Liu Y; Herrmann M
    Immunol Res; 2024 Jun; 72(3):418-429. PubMed ID: 38133855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients.
    Schioppo T; Argolini LM; Sciascia S; Pregnolato F; Tamborini F; Miraglia P; Roccatello D; Sinico RA; Caporali R; Moroni G; Gerosa M
    Rheumatology (Oxford); 2022 May; 61(5):1928-1935. PubMed ID: 34352079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study.
    Ramirez GA; Gerosa M; Bellocchi C; Arroyo-Sánchez D; Asperti C; Argolini LM; Gallina G; Cornalba M; Scotti I; Suardi I; Moroni L; Beretta L; Bozzolo EP; Caporali R; Dagna L
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
    Izmirly PM; Kim MY; Samanovic M; Fernandez-Ruiz R; Ohana S; Deonaraine KK; Engel AJ; Masson M; Xie X; Cornelius AR; Herati RS; Haberman RH; Scher JU; Guttmann A; Blank RB; Plotz B; Haj-Ali M; Banbury B; Stream S; Hasan G; Ho G; Rackoff P; Blazer AD; Tseng CE; Belmont HM; Saxena A; Mulligan MJ; Clancy RM; Buyon JP
    Arthritis Rheumatol; 2022 Feb; 74(2):284-294. PubMed ID: 34347939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2.
    Zavala-Flores E; Salcedo-Matienzo J; Huamanchumo-Guzman R; Berrocal-Kasay A; Alarcón GS
    Lupus; 2024 Mar; 33(3):282-288. PubMed ID: 38237938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia.
    Espinosa G; Prieto-González S; Llevadot M; Marco-Hernández J; Martínez-Artuña A; Pérez-Isidro A; Rifé E; Cervera R
    Clin Rheumatol; 2021 May; 40(5):2057-2063. PubMed ID: 33677725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
    Ramirez GA; Gerosa M; Beretta L; Bellocchi C; Argolini LM; Moroni L; Della Torre E; Artusi C; Nicolosi S; Caporali R; Bozzolo EP; Dagna L;
    Semin Arthritis Rheum; 2020 Oct; 50(5):1150-1157. PubMed ID: 32927376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of Lupus patients during the COVID-19 pandemic.
    Mason A; Rose E; Edwards CJ
    Lupus; 2020 Nov; 29(13):1661-1672. PubMed ID: 33059530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
    Kabeerdoss J; Danda D
    Int J Rheum Dis; 2020 Aug; 23(8):998-1008. PubMed ID: 32779341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
    Zavala-Flores E; Salcedo-Matienzo J; Quiroz-Alva A; Berrocal-Kasay A
    Clin Rheumatol; 2022 May; 41(5):1349-1357. PubMed ID: 34782941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.